BackAlpha Healthcare Acquisition III - Warrants (01/04/2026) Overview
Alpha Healthcare Acquisition Corp III - Warrants (01/04/2026)

Alpha Healthcare Acquisition III - Warrants (01/04/2026) Return on Equity

Alpha Healthcare Acquisition III - Warrants (01/04/2026) (ALPAW) has a ROE of 78.49%, above the sector sector average of -5.72%.

Get informed when a big investor buys or sells

+ Follow

ROE

78.49%

Return on Equity

78.49%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Alpha Healthcare Acquisition III - Warrants (01/04/2026) (ALPAW) FAQ

The latest ROE for ALPAW is 78.49%. That is above the sector sector average of -5.72%. Investors often review this figure alongside Alpha Healthcare Acquisition III - Warrants (01/04/2026)'s historical trend and sector peers before judging valuation or financial health.

Against its sector companies, ALPAW currently prints 78.49% for ROE, while the sector average sits near -5.72%. That is roughly 1471.6% above the sector mean. Large gaps often invite a closer look at Alpha Healthcare Acquisition III - Warrants (01/04/2026)'s growth, margins, and balance sheet.

Return on Equity shows how effectively Alpha Healthcare Acquisition III - Warrants (01/04/2026) converts resources into returns. At 78.49%, ALPAW may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ALPAW's ROE (78.49%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.